we are resonant clinical solutions 

In his role as Chief Executive Officer at Resonant Clinical Solutions, Christophe Berthoux draws from over 30 years of leadership experience in the healthcare sector across Europe and the U.S. He previously held roles at NAMSA, Citoxlab, and Synexus and spent two decades in senior roles at Charles River Laboratories. He also serves on the boards of IAG, FutureMeds, and Aetion. Christophe holds a DVM from École Nationale Vétérinaire de Lyon and an MBA from Purdue University’s Daniels School of Business.

Scott Hickey is CFO of Resonant Clinical Solutions. He has held CFO roles at Natus Medical, A&E Medical (Zimmer Biomet), and Acessa Medical (Hologic), and private equity operating roles with The Riverside Company and American Capital. Prior to this, he spent 15 years at KPMG LLP as a Director in their M&A practice advising private equity and strategic buyers and as a Sr. Manager in their assurance practice. He earned a BBA from Siena College.

As Chief People Officer, Sherry Mennenga brings over 25 years of executive leadership experience tying corporate strategy to performance, talent, and cultural initiatives. Her background includes diverse industry experience in medical device/technologies, building material technologies, manufacturing, consumer goods, and healthcare services. She has served as an HR executive for global and domestic businesses spanning public and private equity structures. Sherry is recognized for leading change in complex environments, creating organizational and HR frameworks that are scalable and enable profitable growth, developing leaders, and modernizing processes. Sherry holds a Master’s Degree in Human and Organizational Development from Vanderbilt University and a Bachelor’s of Science in Business Administration.

As Managing Director, Martin Forster is a key commercial leader within Resonant’s Equipment & Ancillaries business unit, supporting global clinical trials with equipment, ancillary supplies, IOR/EOR capabilities, and specialized calibration services. Martin brings over 25 years of experience in life sciences research and leadership to Resonant’s team and clients, including scientific roles at EMBL and the Leibniz Institute of Virology. He holds a Master’s degree in Chemistry from the University of Hamburg. He was founder and CEO of Labfish, which was acquired by Resonant in September 2026.

As Vice President, General Manager of Equipment & Ancillaries, Stewart Stevenson leads product, supply chain, and lifecycle management for clinical trials at Resonant Clinical Solutions. He brings over 20 years of experience in operations, supply chain and general management having held senior leadership roles at Avantor Sciences and Nutreco. Stewart holds an MSc in Lean Operations from Cardiff University and an Honours degree in Accounting from the University of Central Lancashire (UCLan).

As Vice President, General Manager of Biorepository, Corey Stone oversees biorepository global operations at Resonant Clinical Solutions. Corey is a seasoned biotechnology executive with two decades of leadership experience driving innovation and growth across regulated life sciences sectors. Most notably, Corey served as Senior Vice President of Innovation at AlloSource, one of the world’s leading tissue banks, where he launched novel human cell and tissue products and established a new business vertical grounded in scientific rigor and customer-centric design, providing source material for cell and gene therapy and tissue engineering applications. Corey holds an MBA, is a certified Project Management Professional (PMP), and completed advanced business analytics training at Harvard University.

As Vice President, General Manager of Kitting, Mike McLaughlin oversees kitting operations at Resonant Clinical Solutions, serving both the diagnostic and life sciences industry. Mike is a proven expert with over 20 years of leadership experience in medical supply distribution services, as well as procedural and diagnostic kitting manufacturing. He led Cardinal Health’s Aero-Med business during COVID-19, meeting surging demand in laboratory services while optimizing logistics and advancing innovation in life science product distribution.

Serving as Vice President of Global Business Development, Arbi Harootoonian brings over 20 years of experience in the life sciences industry. With a foundation in laboratory science and executive leadership at Therapak, he played a pivotal role in the company’s acquisition by VWR and the integration of EPL and MESM. He led commercial teams at Avantor Clinical Services and now spearheads global growth strategies at Resonant Clinical Solutions. Arbi holds an MBA degree from Pepperdine University and a BS in Biology.

Jim Rubbo brings deep expertise in mergers, acquisitions, and post-integration strategy to his role as Vice President, Strategic Initiatives at Resonant Clinical Solutions. A seasoned life sciences executive, Jim combines technical insight with business acumen to lead complex integrations and support scalable growth. He is a proud alumnus of Drexel University.

In his role as Vice President, Legal at Resonant Clinical Solutions, William Miller oversees all legal matters across the organization, drawing from his extensive experience in legal strategy and governance within the biotech and life sciences sectors. William began his legal career at Hogan Lovells LLP in the Corporate, Securities & Finance group, previously served as Head of Corporate Law at ImmunoGen, and has held senior legal positions at Novartis and Ipsen.